New methods in scalable compute cloud environments not only accelerate drug discovery in a cost-effective manner, but also deliver reduced deployment time, accelerated GPU speed, and reduced infrastructure costs. Join researchers, scientists, drug discovery CROs, chief technology officers, chief information officers and more for this valuable discussion on the key benefits of implementing a software-as-a-service (SaaS) platform for life science companies. Discover how incredibly fast and simple it can be to deploy a complex full-stack HPC environment, and why that matters.

Presented By

Dr. Tara Madhyastha
Senior Solutions Architect Rescale
Rescale

Anthony Costa
Global Lead Life Sciences Alliances
NVIDIA

About Rescale

Rescale provides high performance computing built for the cloud to empower engineers while giving IT security and control. The Rescale platform makes it simple for engineers and scientists to harness the most advanced software and computing architectures for cutting-edge simulation and AI-driven innovation. For IT, the Rescale platform provides full-stack security and support, and delivers policy-based financial and architectural controls to maximize performance and efficiency. Rescale powers the world’s leading companies to accelerate innovation across industries including life sciences, automotive, energy, semiconductor, aerospace, and manufacturing.